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ABSTRACT The importance of understanding themechanism of protein aggregation into insoluble amyloid ﬁbrils lies not only in
its medical consequences, but also in its more basic properties of self-organization. The discovery that a large number of
uncorrelated proteins can form, under proper conditions, structurally similar ﬁbrils has suggested that the underlying mechanism
is a general feature of polypeptide chains. In this work, we address the early events preceding amyloid ﬁbril formation in solutions
of zinc-free human insulin incubated at low pH and high temperature. Here, we show by time-lapse atomic force microscopy
that a steady-state distribution of protein oligomers with a quasiexponential tail is reached within a few minutes after heating.
This metastable phase lasts for a few hours, until ﬁbrillar aggregates are observable. Although for such complex systems
different aggregation mechanisms can occur simultaneously, our results indicate that the preﬁbrillar phase is mainly controlled by
a simple coagulation-evaporation kinetic mechanism, in which concentration acts as a critical parameter. These experimental
facts, along with the kinetic model used, suggest a critical role for thermal concentration ﬂuctuations in the process of ﬁbril
nucleation.
INTRODUCTION
Self-assembly of proteins or peptides into linear elongated
structures known as amyloid ﬁbrils is a conserved feature
accompanying the clinical manifestation of many patholo-
gies, such as Systemic Amyloidosis or several neurodegen-
erative diseases (Alzheimer’s disease, transmissible spongiform
encephalopathy, etc.) (1,2). In several cases, ﬁbril formation
is regarded as the onset and the cause of such diseases
(‘‘amyloid hypothesis’’) (3). More generally, a large number
of uncorrelated proteins share the possibility of assembling
into similar ﬁbrillar structures under appropriate conditions,
which typically favor nonnative conformations (4,5). There-
fore, the study of ﬁbrillation kinetics is important for under-
standing the processes and interactions involved in amyloid
self-assembly and designing molecular inhibitors.
The 51-residue hormone insulin has long been known
to form ﬁbrils if heated at low pH (6,7), that is, when mono-
meric or dimeric forms are promoted (8,9). Indeed, insulin is
protected from ﬁbrillation by assembling into Zn-hexamers
during in vivo storage or in artiﬁcial delivery systems
(10,11). In acidic conditions, insulin aggregation proceeds
mainly via three steps (12–14): formation of active centers
(nucleation), elongation of these centers to ﬁbrils (growth),
and ﬂoccule formation (15). This is a typical scheme for
protein polymerization (16) or amyloid formation (17–19).
More recently, the structure of insulin ﬁbrils has been shown
to resemble that of typical amyloid ﬁbrils with the charac-
teristic cross b-structure (20–23).
To understand the molecular mechanism responsible for
the appearance of ﬁbrils, it is necessary to get insight into the
early stages of the process. Observation of partially folded
intermediate conformations in conditions preceding insulin
ﬁbril formation provide a molecular insight into the inter-
actions involved (24–29), yet the onset of aggregation and
the causes leading to ﬁbril nucleation and elongation are not
clearly understood.
The early stages of ﬁbrillogenesis are, in general, difﬁcult
to investigate due to the inherent instability of such systems.
Quenching the incubating solution to low temperature allows
molecular weight ﬁltering and circular dichroism experi-
ments (30), but the information one obtains concerns condi-
tions different from the incubating ones. Light scattering
(18,31) is particularly suited to detect either large supramo-
lecular aggregates or protein-size objects at sufﬁciently high
mass concentration, and consequently it misses the early
events in ﬁbrillation kinetics. Neutron scattering has been
used to detect small ﬁbrillar precursors (32), but needs long
measurements, and thus one can obtain but time-averaged
quantities. Atomic force microscopy (AFM) is a technique
that can detect ﬁne-grained features of samples deposited on
a substrate (the resolution corresponding to the inverse cur-
vature of the tip, which is ;5 nm). Time-lapse AFM has
been used extensively to observe the structure and growth of
amyloid ﬁbrils (33,34).
In this work, we performed AFM experiments during ﬁ-
brillation of human insulin. We chose to deposit a small
aliquot of incubated solutions, rather than to perform in situ
AFM, to avoid the effects of surfaces, which are known to
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affect insulin aggregation (35). In particular, we focused on
the early stages preceding the observation of mature ﬁbrils.
To explore the lag phase with sufﬁcient time-resolution, we
used zinc-free recombinant human insulin, since in this case
ﬁbril formation takes place on a timescale of hours (9,29)
and it is slower than that of the best studied bovine insulin
(36–41). AFM snapshots at different times show a distribu-
tion of ellipsoidal oligomeric aggregates, consistent with
analogous ﬁndings in other amyloidogenic systems, such as
the Alzheimer’s amyloid b(1–40) peptide (42–45) or other
proteins (46,47). After 4 h of incubation, ellipsoidal protein
oligomers disappear from AFM images and amyloid ﬁbrils
of different length begin to be detected, with a structure
analogous to that observed for bovine insulin ﬁbers (23,41).
Such changes in aggregate distribution and shape occur with-
in the experiment time resolution of 30 min.
It is unlikely that, for a physical system characterized by
such a molecular complexity as a monomer of insulin, a single
aggregation mechanism takes place, as in the case of simpler
phase transitions, such as liquid crystals. However, one wishes
to identify, if it exists, the main driving mechanism which
causes the transition from a homogeneous solution of insulin
to ordered ﬁbrils.
A primary ﬁnding from our experiments is that the olig-
omer distribution is stationary during the lag-phase and it
exhibits an exponential tail. The median values of this dis-
tribution are consistent with electrospray mass-spectrometry
experiments performed on bovine insulin in analogous con-
ditions (20), but also larger oligomers, up to several tens,
are involved. This metastable phase can be explained by a
coagulation-evaporation process that has been proposed for
colloidal aggregation (48). As to this model, the existence of
a stationary oligomer distribution is critically controlled by
protein concentration. Consequently, we could argue that
small local concentration ﬂuctuations are enough to make the
system cross to the dynamical phase characterized by large
‘‘elongated’’ growing clusters.
Our work is thus in harmony with experimental obser-
vations (49,50) and theoretical studies (51,52) of protein
clusters distributions in conditions promoting protein crys-
tallization. Our results shed a new light on the current view
of ﬁbril nucleation, suggesting a relevant role for thermal
ﬂuctuations and protein-protein interactions leading to clus-
ter formation rather than to physical ﬁbrillar precursors.
MATERIALS AND METHODS
Sample preparation
Recombinant human insulin powder (purchased from Sigma Chemical Co.
(St. Louis, MO) and used without further puriﬁcation) was directly dissolved
at 5C in buffer solution (50 mM KCl/HCl in Millipore SuperQ water, pH
1.6 at 60C). The protein solution was gently stirred, ﬁltered through a
0.22-mm Millex-GV ﬁlter (Millipore, Bedford, MA) into glass cells, and
incubated at 60C. Insulin concentration was 200 mM as measured by
ultraviolet absorption at 276 nm using an extinction coefﬁcient of 1.0675
for 1.0 mg/ml. The ﬁnal concentrations were consistent with those calculated
by weighting insulin powder, thus conﬁrming that essentially no material
was lost through ﬁltering and that insulin was efﬁciently dissolved. After
given time intervals, 10 ml of incubated protein solution were diluted into
1 ml buffer solution, quenched to 0C to rapidly inhibit further aggregation,
and used for atomic force microscopy experiments. All chemicals were ana-
lytical grade.
Atomic force microscopy
A few ml of the insulin solution were dropped onto a freshly cleaved mica
substrate (quality ruby muscovite). After a few minutes, the sample was
washed dropwise with Millipore SuperQ water, and then dried with a gentle
stream of dry nitrogen. Images of the protein aggregates were recorded with
a Multimode Nanoscope IIIa AFM (Veeco Instruments, Santa Barbara, CA),
operating in tapping mode inside a sealed box where a dry nitrogen atmo-
sphere was maintained. We used rigid cantilevers with resonance fre-
quencies of ;300 kHz and equipped with single crystal silicon tips with
nominal radius of curvature 5–10 nm. Typical scan size was 5003 500 nm2
(512 3 512 points), and scan rate was 1–2 Hz.
Static light scattering
Immediately after preparation, samples were placed in a thermostated cell
compartment of a Brookhaven Instruments (Holtsville, NY) BI200-SM
goniometer, equipped with a He-Ne laser (wavelength l0 ¼ 632.8 nm). The
temperature was set at 60C and controlled within 0.05C with a ther-
mostated recirculated bath. Scattered-light intensity at 90 was measured by
using a Brookhaven BI-9000 correlator. Absolute values for scattered in-
tensity (Rayleigh ratio) have been obtained by normalization with respect to
toluene, whose Rayleigh ratio at 632.8 nm was taken as 14 3 106 cm1.
RESULTS AND DISCUSSION
Time-resolved AFM
Our procedure to investigate early stages of insulin ﬁbrilla-
tion consists of incubating the protein in a test tube, extrac-
ting samples every 30 min, depositing it on a substrate, and
scanning it with the AFM (which takes a time of the order of
minutes). The concentration of the protein solution and the
incubation time are such that several monolayers of insulin
aggregates are deposited onto the mica surface. AFM anal-
ysis is carried out on the aggregates belonging to the topmost
layer, which are expected not to interact with the mica
surface, passivated by the very ﬁrst monolayers. Moreover,
the few minutes of drying of protein samples is expected to
remove most of the surface water, while keeping local the
protein aggregates substantially hydrated. We exclude there-
fore the possibility that the protein layers imaged in the dry
nitrogen atmosphere are signiﬁcantly more concentrated than
the layers that would assemble on the mica surface in the
AFM liquid cell. Thus, we obtain snapshots of the aggrega-
tion intermediates until ﬁbrils are formed. Several AFM
images of each sample, representative of a given incubation
time, were recorded. This allowed collecting the topographic
data of;104 aggregates for each incubation time. Snapshots
of the system from the beginning of the incubation (deﬁned
as time zero) up to 9 h are displayed in Fig. 1. Such snapshots
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indicate that there are oligomers, but not ﬁbril-like structures
(cf. Fig. 1, A–C), in the ﬁrst 4 h, until ﬁbrils appear at time
280 min. (cf. Fig. 1, D–F). The overall process can thus be
divided into a long metastable phase, and the growth of the
ﬁbrils. Note that the formation of ﬁbrillar structures is fast
compared with the metastable phase, but it is not a sudden
critical process, as shown by light-scattering kinetics in Fig. 1 F.
AFM data analysis in the early stages of kinetics
A homemade software was used for detecting the edges of the
protein aggregates in the AFM maps (A. Podesta`, P. Piseri,
M. Marino, C. Castelnuovo, and P. Milani, unpublished).
The binary maps obtained were then processed using the
Image Processing Toolbox of MATLAB (The MathWorks,
Natick, MA), and the average distributions of aggregate
areas were obtained, as shown in Fig. 2, A–C.
Deconvolution of the tip shape from AFM images is a
critical issue in any quantitative study of biological samples.
Deconvolution algorithms are likely to introduce artifacts in
the data, especially when the basic features in the AFMmaps
are nanometer-sized. Moreover, the morphology of our sys-
tem, a quasi-two-dimensional close arrangement of nano-
meter-sized objects, without gaps in between, does not allow
the application of simple deconvolution formulas to the dis-
tribution of areas (53). These formulas apply to the case of
parabolic spherical tips scanning isolated objects lying on a
ﬂat reference plane.
We have thus processed raw AFM images without apply-
ing any deconvolution. We expect, indeed, reduced convolution
FIGURE 1 (A–E) Snapshots of insulin aggregation
kinetics at 60C monitored by kinetic AFM. Times elapsed
after incubation: (A) 1 min; (B) 180 min; (C) 250 min; (D)
280 min; and (E) 540 min. The vertical color scale is 5 nm
in A–C and 30 nm in D and E. (F) Rayleigh ratio versus
time. The colored stripe marks the interval between 250
and 280 min, during which ﬁbrils became observable by
AFM.
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effects, because the tip does not penetrate deeply down to the
substrate but only senses the outermost surface of the protein
layer. This insures only negligible lateral contact of the tip
and consequently reduced loss of resolution. In addition, the
underestimation of the area of the aggregates caused by the
erosion of binary maps operated by the edge detection algo-
rithm tends to compensate for the opposite effect produced
by the tip shape convolution.
To show that the effects of tip convolution are negligible,
we analyzed several AFM images of highly diluted samples,
where isolated aggregates lying on the ﬂat mica surface are
visible (;20 complexes every 5003 500 nm2). These model
samples were preprocessed using standard deconvolution
algorithms; we used the formula w9 ¼ w  2(2hRtip)0.5 for a
parabolic tip on a step, where Rtip is the tip radius (assumed
Rtip ;3 nm), h is the step height (h ¼ ;1.1 nm, the average
aggregate height extracted by the AFM images), and w and w9
are the apparent and deconvoluted widths of the observed
features (53). The resulting distributions of areas were in good
agreement with those obtained from the nondeconvoluted raw
AFM images (data not shown). In particular, the median and
standard deviation of the areas were 276 35 nm2 accordingly,
to be compared with the average values of 30 6 22 nm2
extracted from the raw AFM images of concentrated samples.
FIGURE 2 Oligomer distributions in the
course of kinetics. (A–C) Counts of areas
observed in AFM images of Fig. 1, A–C,
respectively. (D–F) Frequency of occur-
rence of aggregation numbers of objects
observed in the AFM images of Fig. 1,
A–C, respectively. Solid lines are ﬁt by
Eq. 2.
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Quantitative estimation of aggregate size from areas rather
than from heights is more reliable because the peculiar ver-
tical interaction of the AFM tip with biological samples
usually leads to underestimation of the true height. The same
effect is caused by the close packing of insulin aggregates in
relatively concentrated samples, which keeps the tip from
getting in touch with the ﬂat reference substrate. Processing
AFM images of concentrated samples, however, allowed us
to collect the large amount of data required to have a stable ﬁt
of the area distributions.
Shape of oligomers
The shape of the aggregates can be characterized by means
of their eccentricity. The eccentricity of the protein aggre-
gates was also evaluated from the binary maps using the
same MATLAB toolbox. Eccentricity is deﬁned as [1 
(a/b)2]0.5, a and b being the minor and major axes, respec-
tively, of the aggregate. This parameter is expected to be 0 for
a circle, and 1 for a segment. Correlations of eccentricity and
areas are shown in Fig. 3, which shows that even this feature
of the system is stationary in the metastable phase. Aggre-
gates have a mean eccentricity of 0.75 that stands for a ratio
between large and small axes of ;1.5. Larger aggregates
have a larger eccentricity than smaller aggregates, evidenc-
ing a preferential one-dimensional (ﬁbrillar) growth for clus-
tering proteins, consistent with recent theoretical ﬁndings on
colloid clusters with both short-range attraction and long-
range repulsion (51,52). Because of the rounding effect of tip
convolution, the measured eccentricity is, at most, an under-
estimate of the actual one.
Average mass of insulin oligomers at the
onset of kinetics
Light-scattering experiments were performed immediately
after incubation at 60C. Measurement of the intensity scat-
tered at 90 (scattering vector q ¼ 18.6 mm1) provides the
Rayleigh ratio IR(q), which is related to the weight average
molecular mass Mw by the relation IRðqÞ ¼ 4p2n˜2ðdn˜=dcÞ2
l40 N
1
A cMwPzðqÞ; where c is mass concentration, n˜ is
medium refractive index, l0 is incident wavelength, NA
is Avogadro’s number, and Pz(q) is the z-averaged form
factor (31). By taking (dn˜/dc)¼ 0.18 cm3 g1, and Pz(q)¼ 1
(since the initial size of solutes is much smaller than q1),
we obtain an average molecular mass of 10 6 2 kDa.
Considering that the molecular mass of a single insulin
molecule is 5806 Da, the mean average aggregation number
of insulin oligomers found at the onset of kinetics is 1.7 6
0.3. Note, however, that the latter value, obtained by light-
scattering measurements, corresponds to the ratio between
the second and the ﬁrst moment of oligomer distribution
(31), and gives no information on the actual distribution
shape.
Oligomer distribution preceding
amyloid formation
Volumes of imaged objects were derived from calculated
areas and eccentricities, under the assumption that the aggre-
gates are prolate ellipsoids. Aggregation numbers, n, are
obtained by using the relation V¼ V0n1/d, where V0¼ 14.1 nm3
is the van der Waals volume of an insulin monomer, in-
cluding a layer of water, derived from the x-ray structure
FIGURE 3 Size-eccentricity correlation. (A–C) Correlation of eccentricity
and areas of objects observed in the AFM images of Fig. 1, A–C, re-
spectively. Dotted curves represent average eccentricity versus aggregate
area.
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(54), and d ¼ 2.68 is an effective fractal dimension that
accounts for the scaling between mass and size of aggre-
gates. The value d ¼ 2.68 is derived from x rays and light-
scattering data (54–56) on oligomers of zinc-free insulin at
high pH. Note that zinc-free insulin is not tightly packed nor
is it assembled into toroid-shaped hexamers like zinc insulin.
We have found that by assuming an effective fractal dimen-
sion between 2 (enough loose aggregates) and 3 (space-
ﬁlling objects), the shape of oligomer distribution is not
signiﬁcantly altered, that is, the distribution shape is robust
with respect to different reasonable choice of molecular
packing. This distribution implies that aggregates built from
up to 50 monomers are detectable in the initial stages of ag-
gregation. The large size of these oligomers is in agreement
with the micellar precursors identiﬁed in Lomakin et al. (18)
in the case of Alzheimer’s amyloid b-peptide.
The distribution of oligomer aggregation numbers at
different times in the metastable phase is displayed in Fig. 2,
D–F. All the curves well overlap, indicating that the dis-
tribution of size is stationary. The median aggregation num-
bers, nm, are 5.9, 4.9, and 6.7, respectively, for the three cases
shown in the ﬁgure. The tail of such distributions can be ﬁt
by an exponential of the kind exp(n/nm) (cf. Fig. 2), where
nm is the median aggregation number.
Note that according to the kinetic model described, as well
as to the light-scattering results, the majority of the protein
should be in the monomeric or dimeric form. However, it is
not surprising that such small species are hidden in the
crowded AFM images, or confused among the smallest frag-
ments in the binary maps of aggregates generated by the edge-
detection algorithm, and thus ﬁltered out. Consistently, we
afford a statistical analysis of oligomer distribution by con-
sidering only the higher concentration numbers.
Kinetic model for oligomer distribution
The most evident feature of the distributions of oligomer
size and aggregation number shown in Fig. 2 is that they
reach a steady state within the time detectable from the
experiment (i.e., a few minutes). A steady state means that,
unlike diffusion-limited or reaction-limited mechanisms,
which regulate the assembly of larger aggregates (19), in
this case we deal with an ‘‘evaporation’’ process (i.e., mono-
mers leaving the aggregates), which competes with ‘‘co-
agulation’’. To perform AFM experiments, samples have
been manipulated by the procedures described above. In
particular, sample dilutions alter profoundly the initial ther-
modynamic conditions. However, such intrinsic weakness of
the experimental approach conﬁrms that the observed dis-
tribution is due to a kinetic coagulation process. Indeed, by
applying bare thermodynamic equilibrium between different
oligomeric species, one would expect that upon such dilution
insulin would be essentially monomeric (8).
A mechanism for protein association that accounts for
both aggregation and evaporation processes can be outlined
in the framework of classical coagulation theory (57). If we
call rn(t) the number concentration of aggregates built out of
n monomers at time t, the rate equation of the system reads:
d
dt
rnðtÞ ¼ +
n1
i¼1
ðn.1Þ
KiðniÞ riðtÞ rðniÞðtÞ  rnðtÞ+
N
j¼1
Knj rjðtÞ
1 ln11rn11ðtÞ  lnrnðtÞ1 dn1 +
N
j¼1
lj rjðtÞ; (1)
where dij ¼ 1 for i ¼ j, and zero otherwise. The ﬁrst two
terms in the right-hand side of the latter equation are, respec-
tively, the production and loss of n-mers by coagulation of
two clusters of i and j proteins, whereas the other terms de-
scribe the ‘‘evaporation’’ of one monomer from a cluster of
n 1 1 proteins into a cluster of n proteins and a single pro-
tein. Here, we include no nucleation term, and we also as-
sume that three-body effects can be ignored.
The simplest solution of such equations has been provided
by Krapivsky and Redner (48) by taking mass independent
rate constants, Kij ¼ K and li ¼ l, and assuming that only
monomers are present at time zero, that is rnð0Þ ¼ cM10 dn1;
where c is the total mass concentration and M0 is the mass
of a monomer.
The model displays two behaviors, controlled by the
parameter m ¼ Kl1cM10 ; that is, by the ratio between the
coagulation and evaporation rate constants and by the initial
concentration of monomers. At low protein concentration
(m , 1) the system displays a steady-state distribution
P(n) ¼ rn/Srn with an asymptotic tail that is an exponential
times a power law:
PðnÞ ¼ xn1 Gðn
1
2
Þ
Gðn1 1ÞGð1
2
Þ 1
n 1
2
n1 1
x
 
; (2)
where x ¼ m(2 m). At m ¼ 1, the system displays a power-
law distribution, whereas at higher concentrations (m . 1) it
does not display any steady state, the typical cluster growing
linearly in time.
The tails of the distributions shown in Fig. 2, D–F, are
well ﬁt by Eq. 2, indicating that the system is in the low-
concentration regime. For the three distributions, one ob-
tains, respectively, m ¼ 0.71, 0.66, and 0.73. The mass
averaged mean aggregation number nz, which is accessible
through scattering experiments and is found to be 1.76 0.3,
can be expressed in terms of this model as the ratio between
the second and the ﬁrst moment of the distribution: nz ¼
(1  m)1 ¼ 3.3 6 0.4. This slight discrepancy between
light-scattering and AFM results points out the lack of mono-
meric and dimeric oligomers from AFM images, as discussed
above. Also, note that a simple-minded exponential (maximum-
entropy) distribution would give a worse ﬁt and a much
higher mass averaged mean aggregation number (nz ¼ 11.6
6 1.9).
Due to the large value observed for the parameter m, one
could speculate that local ﬂuctuations in the density of mono-
mers could be the triggering mechanism behind the onset of
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ﬁbril formation, akin to that proposed for crystal nucleation
(58,59). Note that this does not imply a break of symmetry,
since the metastable aggregates already display a pronounced
eccentricity.
The kinetic model used needs no assumption concerning
thermodynamic equilibrium. Also, the experimental procedure
alters the initial thermodynamic conditions. Notwithstand-
ing, it is interesting to consider the free-energy change
involved in the clustering process if one assumes a ‘‘meta-
stable’’ equilibrium condition. In particular, one can deﬁne
the free energy DGn associated with the addition of one mono-
mer to a cluster of n proteins, as DGn ¼ kBTln( fn11/fnf1),
where kB is the Boltzmann constant and fn is the activity of a
cluster of n proteins. If we take the activity as fn ¼ cn/c, with
cn the mass concentration of the n-mers and c the total
concentration, we obtain for an inﬁnitely large cluster
DGN
kBT
¼ ln 2m
1 1
4
mð2 mÞ: (3)
From our analysis, we obtained DGN ¼ 0.6 kBT. There-
fore, the free energy related to the growth of a large cluster or
ﬁber is easily accessible through thermal ﬂuctuations. This
gives a rationale for the fact that in insulin, as well as in other
protein solutions, a change in temperature or in solvent con-
ditions can trigger ﬁbril formation (60).
CONCLUSION
In this work, the early stages of human insulin ﬁbrillation
have been monitored by time-lapse AFM, a technique with
high resolution and sensitivity. Experimental observations
and theoretical modeling highlight an interesting scenario of
the nucleation mechanism preceding amyloid ﬁbrillation:
1. Experiments show that, within the limits of resolution of
the AFM, a steady-state distribution of protein oligomers
with an exponential tail is present in solution up to the
point of formation of amyloid ﬁbrils (Figs. 1 and 2).
2. Oligomer distribution can be explained by a kinetic
model that combines coagulation and evaporation events
(Fig. 2, D–F). As to this model, the formation of ‘‘non-
stationary’’, growing aggregates is controlled by mono-
mer concentration. In this case, concentration is below
the critical value, yet sufﬁciently high to allow ‘‘above-
threshold’’ thermal concentration ﬂuctuations. It should
be remarked that although our scheme captures an inter-
esting feature of insulin aggregation, its generalization to
different thermodynamic conditions and concentrations
is not straightforward due to the complex hierarchy of
structures and processes involved (34).
3. Preﬁbrillar oligomers exhibit a marked eccentricity
(Fig. 3), denoting that the symmetry breaking implied by
the existence of ﬁbrillar aggregates has already occurred
before ﬁbrillation. Indeed, it is reasonably related to a
‘‘fast’’ conformational change (22,25,29). From the latter
experimental results, we can argue that such oligomers
are actual ‘‘on-pathway’’ intermediates of mature ﬁbrils.
The appearance of mature amyloid ﬁbrils seems fast when
compared with the duration of the lag phase and if detected
within the time resolution of the experiments, which is 30
min. However, it is not a critical process, as shown by the
kinetics of Fig. 1 F. The details of the actual mechanism of
ﬁbril formation are not visible in the main structural in-
formation obtained by AFM experiments. Indeed, the ob-
servations presented here enable us to grasp the main
structural features of the mechanism controlling the size of
the objects in solution during the lag phase. Also, along with
the extremely naı¨ve model used, they show that these aggre-
gates are formed by a kinetic process.
The existence of preﬁbrillar precursors acting as aggrega-
tion nuclei has been widely observed in amyloid formation
both as preexisting seeds and as actual self-assembled nuclei
(17). Our results point out that, along with the existence of
such precursors, local density ﬂuctuations may play a critical
role in the nucleation mechanism and trigger amyloid
ﬁbrillogenesis.
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